Iron-deficiency anemia is a common complication of chronic kidney disease (CKD). It happens when your body doesn't have enough iron. You need iron to make the protein hemoglobin, which helps your red ...

The presence and severity of anemia in kidney disease increasesmarkedly with lower estimated glomerular filtration rates (eGFRs) and is associated with multiple adverse outcomes, a large cohort study ...

ORLANDO, Fla.—Mitochondrial DNA copy number (mtDNA) and plasma levels of hepcidin hold promise as novel markers of anemia in CKD patients, data suggest. Madhumathi Rao, MD, Assistant Professor of ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

A new study used German data to assess the effects of CKD, anemia, or both on the development and eventual progression of HF among at-risk and symptomatic patients. The prevalence and severity of CKD ...

Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease. Ziltivekimab, a novel anti-IL-6 ligand antibody, improves ...

Credit: Getty Images. Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. The Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat) for the treatment of ...

Akebia Therapeutics, Inc. AKBA announced that the FDA has approved its Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD). The eligible patient population for ...

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and ...

Medically reviewed by Oliver Eng, MDKey TakeawaysBlood cancers like leukemia hinder the production of red blood cells, ...